Pearltrader

 
 
 
Login Forgot your password?

Create new account

Medigene / Ranking / (WKN: 502090)

Rating   Category
83%  

Estimation of Market Cap

overvalued, realistic, undervalued
83%  

Management

experienced & ambitious, suitable for the company
83%  

News (Quality)

Qualitative not top quality, adequate, first-class
83%  

News (Quantity)

Quantitative not top quality, adequate, first-class
83%  

Businessmodel

not profitable, lucrative, excellent marketpositions
83%  

Branche

market is saturated, stagnative market, excellent marketposition is supposable
66%  

Investor Relations

External Presentations
83%  

Website

informative, qualitative & opitcal high class
100%  

Chart developement

Stock price at a loss, stagnated, gained value
83%  

2 users ranked this company

 

User who ranked the company

Date Time Username Rating
14.07.2010 00.40

immerwieder

66%
11.07.2010 18.41

100%